Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × PE regimen × Other solid neoplasm × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Other solid neoplasm 1 Genitourinary 1 Endocrine 1

Conditions

Solid Tumor Cancer 1

Interventions

Cisplatin 55 Carboplatin 49 Pemetrexed 42 Cyclophosphamide 42 Irinotecan 32 pembrolizumab 28 Paclitaxel 28 Gemcitabine 26 Etoposide 24 Bevacizumab 23 Nivolumab 21 Capecitabine 20 Vincristine 19 Oxaliplatin 18 Interviews as Topic 18 fludarabine 17 Topotecan 17 Temozolomide 17 Sorafenib 17 Leucovorin 17 Filgrastim 17 Early Intervention, Educational 17 Docetaxel 17 Radiotherapy 16 Specimen Handling 15 Fluorouracil 15 Everolimus 15 Educational Status 15 Drug Therapy 14 Doxorubicin 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡